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ABSTRACT 25 
Attention Deficit Hyperactivity Disorder (ADHD) commonly affects children, although 26 
the symptoms persist into adulthood in approximately 50% of cases. Structural 27 
imaging studies in children have documented both cortical and subcortical changes 28 
in the brain. However, there have been only a few studies in adults and the results 29 
are inconclusive. Method: Voxel-based morphometry (VBM) was applied to 44 adults 30 
with ADHD, Combined subtype, aged 18-54 years and 44 healthy controls matched 31 
for age, sex and IQ. Results: ADHD patients showed reduced grey matter (GM) 32 
volume in the right supplementary motor area (SMA). Using more lenient thresholds 33 
we also observed reductions in the subgenual anterior cingulate (ACC) and right 34 
dorsolateral prefrontal (DLPFC) cortices and increases in the basal ganglia, 35 
specifically in the left caudate nucleus and putamen. There was a positive correlation 36 
between the cumulative stimulant dose and volume in the right SMA and DLPFC 37 
clusters. Conclusions: The findings suggest that adults with ADHD show brain 38 
structural changes in regions belonging to the so-called cool executive function 39 
network. Long-term stimulant medication may act to normalize these GM alterations. 40 
 41 
Key words: ADHD, Neuroimaging, Voxel-Based Morphometry, Methylphenidate, 42 
supplementary motor area, anterior cingulate cortex, dorsolateral prefrontal cortex. 43 
 44 
 45 
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1. Introduction 48 
 49 
Attention Deficit Hyperactivity Disorder (ADHD) is one of the most prevalent 50 
neuropsychiatric disorders, affecting about 5% of children (Polanczyk et al., 2007). 51 
Although it was originally believed to be a disorder of childhood, there is evidence 52 
that the symptoms persist into adulthood in approximately 50% of cases (Pironti et 53 
al., 2014). In adults, symptoms of hyperactivity, impulsivity and deficit of attention 54 
tend to be expressed in the form of inner restlessness, inability to relax, impatience, 55 
difficulty to make decisions, affective instability and stress intolerance (Kooij et al., 56 
2010). These symptoms can significantly disrupt patients’ daily life activities, 57 
especially in the absence of adequate coping skills (Amico et al., 2011).  58 
 59 
Numerous structural neuroimaging studies have examined ADHD in children. A meta-60 
analysis of studies using region of interest (ROI) analyses found reductions in overall 61 
brain volume, and in several frontal regions, the posterior inferior cerebellar vermis, 62 
the splenium of the corpus callosum and the right caudate nucleus (Valera et al., 63 
2007) ROI analysis however, has the disadvantage that examined areas are selected 64 
a priori meaning that changes in non-selected areas or in areas that do not conform 65 
to known anatomical divisions may be missed (Rubia et al., 2014). Whole brain 66 
techniques like voxel-based morphometry (VBM) avoid this problem, comparing all 67 
cortical and subcortical grey matter (GM) between patients and controls at once and 68 
automatically generating clusters where changes are maximal (Hoekzema et al., 69 
2012). Studies applying VBM to children with ADHD have broadly confirmed the 70 
findings of ROI studies but have documented a more detailed pattern of volume 71 
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reductions in the frontal lobe, including the dorsolateral and orbitofrontal cortices, as 72 
well as finding volume reductions in subregions of the temporal, parietal and occipital 73 
lobes and the anterior and posterior cingulate cortex (Cubillo et al., 2012; De La 74 
Fuente et al., 2013; Hoekzema et al., 2012). Different meta-analysis of these studies 75 
found reductions in GM, especially in the basal ganglia, as well as slightly greater GM 76 
volumes in the left posterior cingulate cortex (Ellison-Wright et al., 2008; Frodl and 77 
Skokauskas, 2012; Nakao et al., 2011). However, the meta-analysis of Nakao et al. 78 
(2011) also found evidence for normalization of the basal ganglia changes with age 79 
and in association with the use of stimulant medication. 80 
 81 
Whereas structural imaging studies of children with ADHD are plentiful, there have 82 
been only a few studies in adults with the disorder. These studies have mostly 83 
focused on evaluating if patients share GM abnormalities in fronto-striato-cerebellar 84 
circuits that sustain attention, inhibition, cognitive control, motivation, and emotion but 85 
the results are inconclusive. Studies using a whole-brain analysis did not detect 86 
significant differences between patients and controls(Amico et al., 2011; Onnink et 87 
al., 2014; Pironti et al., 2014; Seidman et al., 2011; Seidman et al., 2006), except for 88 
the studies of Ahrendts et al. (2011) and Almeida et al. (2010). The former found that 89 
ADHD patients showed a significant reduction in GM volume bilaterally in the 90 
occipital lobes (Ahrendts et al., 2011), and the latter showed reductions in the right 91 
caudate nucleus (Almeida Montes et al., 2010). However, some of these studies in 92 
adult population carried out an exploratory ROI analysis and found that  compared to 93 
healthy subjects, ADHD patients showed deficits in overall cortical GM (Seidman et 94 
al., 2006), various regions within the frontal lobe, including the orbitofrontal and 95 
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dorsolateral cortices and the inferior frontal gyrus, the anterior cingulate cortex, the 96 
parietal and occipital lobes, the cerebellum and the caudate and putamen nuclei 97 
(Almeida Montes et al., 2010; Amico et al., 2011; Hesslinger et al., 2002; Onnink et 98 
al., 2014; Pironti et al., 2014; Seidman et al., 2011; Seidman et al., 2006). Also, one 99 
study reported an increase of GM volume in regions within the occipital and parietal 100 
lobes, the dorsolateral prefrontal cortex and the dorsal mid cingulate cortex in ADHD 101 
patients relative to controls (Pironti et al., 2014).  102 
 103 
The discrepancies between childhood and adult brain structural findings in ADHD 104 
could be genuine, perhaps reflecting the above mentioned meta-analytic finding that 105 
increasing age and treatment with stimulants may tend to normalize brain structure 106 
(Nakao et al., 2011). Alternatively, they could simply be a function of the relative lack 107 
of studies in ADHD adult population, their generally smaller sample sizes, or possibly 108 
other factors related to the inclusion of comorbid conditions or no discrimination 109 
between ADHD subtypes (Cortese and Castellanos, 2012; Spencer et al., 2013).  110 
 111 
In the present study, we evaluated changes in a larger sample of adults with ADHD 112 
and controls using a VBM analysis. We also investigated the association between 113 
changes found and clinical factors and exposure to stimulant medication.  114 
 115 
 116 
 117 
 118 
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2. Methods 119 
 120 
2.1. Participants 121 
 122 
Forty-six right-handed adult ADHD combined subtype (ADHD-C) were recruited from 123 
the Hospital Universitari Vall d’Hebron and the Benito Menni CASM. Two ADHD 124 
patients were excluded from the analyses due to movement in the MRI images, 125 
therefore, our final sample consisted of forty-four patients (demographic data for the 126 
sample is shown in Table 1).  127 
 128 
Clinical diagnosis was made by a team of ADHD expert psychiatrists and 129 
psychologists, based on the Diagnostic and Statistical Manual of Mental Diseases, 130 
Fourth Edition, Test Revised (DSM-IV-TR) (APA., 2004) and confirmed with the 131 
Conners’ Adult ADHD Diagnostic Interview for DSM-IV (CAADID) (Epstein and 132 
Johnson, 1999; Ramos-Quiroga et al., 2012), the Wender Utah Rating Scale (WURS) 133 
(Ward et al., 1993), the ADHD Rating Scale (DuPaul, 1998) and the Conners Adult 134 
ADHD Rating Scale (CAARS) (Conners, 1999). Exclusion criteria were (a) age 135 
younger than 18 or older than 65 years, (b) left-handedness, (c) history of brain 136 
trauma or neurological disease, and (d) substance use disorder (abuse/dependence) 137 
of drugs including cocaine, heroin, synthetic drugs or alcohol. All subjects were 138 
evaluated to exclude comorbidity with other major psychiatric or personality disorders 139 
using the Structured Clinical Interview for Axis I (SCID-I) (First et al., 2002) and Axis II 140 
(SCID-II) (First et al., 1997) respectively to prevent that the findings of our study 141 
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reflected brain abnormalities not related to ADHD per se but to its comorbid 142 
disorders.  143 
 144 
Twenty-nine patients were medicated only with methylphenidate (mean ± SD; relative 145 
daily doses (mg/day) 42.24 ± 16.17; treatment duration (months) 25.20 ± 24.41) and 146 
15 had never received any pharmacological treatment. The stimulant-treated ADHD 147 
patients were discontinued at least 4 days prior to the MRI. 148 
 149 
The control sample consisted of forty-four right-handed healthy individuals recruited 150 
from non-medical staff working in the hospital Benito Menni CASM, their relatives and 151 
acquaintances, plus independent sources in the community. They met the same 152 
exclusion criteria as the ADHD group. Although they were not assessed using 153 
specific clinical scales of ADHD, they were interviewed by a group of clinical 154 
psychologists and were excluded if they had any psychiatric disorder or were taking 155 
any type of psychotropic medication other than non-regular use of benzodiazepines 156 
or other similar drugs for insomnia. They were also questioned about family history of 157 
mental illness and excluded if a first-degree relative had experienced symptoms 158 
consistent with major psychiatric disorder and/or if they had received in- or outpatient 159 
psychiatric care. 160 
Both the ADHD and control group were matched for age, gender and IQ, as 161 
estimated by the Word Accentuation Test (Test de Acentuación de Palabras, TAP) 162 
(Del Ser et al., 1997), a test requiring pronunciation of Spanish words whose accents 163 
have been removed. The TAP has been standardized against the Wechsler Adult 164 
Intelligence Scale (WAIS-III) (Wechsler, 2001) and scores can be converted into full-165 
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scale IQ estimates (Gomar et al., 2011).  Both groups were also required to have a 166 
current IQ in the normal rang (>70 points), as measured using two subtests of the 167 
WAIS-III: vocabulary and block design. 168 
 169 
The study was approved by the Ethics Committee of both hospitals and all 170 
participants gave written informed consent. 171 
 172 
2.2. Brain data acquisition 173 
 174 
All participants were scanned in the same 1.5-T GE Signa scanner (General Electric 175 
Medical Systems, Milwaukee, WI, USA) at Sant Joan de Déu Hospital in Barcelona 176 
(Spain) using the following high-resolution structural T1 MRI sequence: 180 axial 177 
slices, 1mm slice thickness with no gap, 512×512 matrix size, 0.5×0.5×1mm3 voxel 178 
resolution, 4ms echo time, 2000ms repetition time, 15° flip angle. 179 
 180 
2.3. Image processing 181 
 182 
Raw structural images had the non-brain matter removed with the ‘brain extraction 183 
tool’ (BET) (Smith 2002) and were segmented into GM and other tissues with the 184 
FMRIB software library (FSL) (Zhang et al., 2001). 185 
 186 
Normalization of the GM segments to a common template was conducted with the 187 
‘advanced normalization tools’ (ANTS) high-resolution diffeomorphic symmetric 188 
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normalization (SyN) based on directly manipulated free form deformation (Avants et 189 
al., 2008; Avants et al., 2010), which has shown to substantially improve the accuracy 190 
of other methods (Klein et al., 2009). Normalization steps were as follows: a) affine 191 
registration of the native-space GM images to a MNI GM template (voxel-size: 192 
1.5x1.5x1.5mm3); b) creation of a template by the registered GM images; c) non-193 
linear registration of the native-space GM images to the template; and d) four extra 194 
iterations of the steps b and c. Modulated and non-modulated images were 195 
Gaussian-smoothed with a σ=4mm (FWHM=9.4mm) kernel, which has shown to 196 
yield increased sensitivity as compared to narrower kernels (Radua et al., 2014). 197 
 198 
It has been shown that that the non-linear registration is able to capture gross 199 
differences such as brain shape abnormalities, but not more subtle differences such 200 
as fine cortical thinning (Radua et al., 2014). Thus, unmodulated images may better 201 
detect mesoscopic (i.e. between microscopic and macroscopic) differences not 202 
captured by the non-linear registration, as in that case the modulation would only 203 
introduce macroscopic noise, ultimately reducing the statistical power (Radua et al., 204 
2014). Conversely, modulated images may better detect macroscopic differences 205 
captured by the non-linear registration, as a great part of these differences might be 206 
removed during the non-linear registration but re-introduced with the modulation 207 
(Ashburner and Friston, 2001). 208 
 209 
 210 
 211 
 212 
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2.4. Statistical analysis 213 
 214 
Demographic and clinical data. Differences in demographic and clinical 215 
characteristics among the groups were examined using chi-square tests for 216 
categorical variables and independent sample t-tests for continuous variables. 217 
 218 
Inter-group VBM comparisons. Voxel-based anatomical differences between patients 219 
and controls were fitted with a general linear model. Sex, age and cumulative 220 
stimulant dose were included as regressors in order to reduce the error of the model; 221 
please note that these variables have known relations with GM volume, and that the 222 
previous matching by sex and age was useful to remove the potential confounding 223 
effect of these variables but not to reduce the within-group variability associated to 224 
them. We used the ‘threshold-free cluster enhancement’ (TFCE) due to its increased 225 
sensitivity as compared to voxel- or cluster-based statistics (Radua et al., 2014; 226 
Salimi-Khorshidi et al., 2011; Smith and Nichols, 2009). Statistical significance was 227 
assessed with the permutation test included in FSL and maps were threholded twice, 228 
once using a family-wise error (FWE) corrected p < 0.05 and once using an 229 
uncorrected p<0.001 (in both cases conventionally excluding clusters with less than 230 
10 voxels). This was on the basis that the former will tend to minimize false positive 231 
results whilst the latter will minimize false negative results (Durnez et al., 2014). 232 
 233 
Correlation analysis. GM volume within clusters of statistically significant difference 234 
between patients and controls was extracted (by) for further analysis within the 235 
patient sample. Specifically, we first computed, for each patient, the mean of the 236 
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voxels included in each cluster and then calculated the Pearson correlation 237 
coefficient between these individual means and the cumulative stimulant dose, the 238 
ADHD Rating Scale scores and the inattention, hyperactivity, impulsivity and ADHD 239 
total subscales of the CAARS in order to explore whether these factors might have 240 
an influence on ADHD GM abnormalities.  241 
 242 
3. Results 243 
 244 
3.1. Participants 245 
 246 
Demographic and clinical data for the ADHD and control groups are shown in Table 247 
1. Both groups were well-matched for age, gender and estimated  premorbid IQ (TAP 248 
score). Both groups did not differ significantly in educational level. 249 
 250 
[Table 1 about here] 251 
 252 
3.2. Modulated VBM analysis 253 
 254 
Compared to the healthy subjects, ADHD individuals showed three clusters of GM 255 
reduction. One was situated in the right supplementary motor area (SMA) extending 256 
to superior frontal lobe (cluster size: 889 voxels; uncorrected p<0.001, FWE-257 
corrected p<0.05; MNI x=8 y=24 z=64), another cluster was located in the subgenual 258 
anterior cingulate cortex (ACC) (cluster size: 53 voxels; uncorrected p<0.001; MNI 259 
x=6 y=18 z=-14) and a third was in the right dorsolateral prefrontal cortex (DLPFC) 260 
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(cluster size: 16 voxels; uncorrected p<0.001; MNI x=48 y=18 z=44). There were no 261 
cortical or subcortical regions where ADHD patients showed more GM volume than 262 
controls (see Table 2 and Figure 1). Findings in ACC and DLPFC did not survive the 263 
correction for multiple comparisons. 264 
 265 
[Table 2 and Figure 1 and 2 about here] 266 
 267 
3.3. Unmodulated VBM analysis 268 
 269 
ADHD patients did not show any brain regions with less GM relative to the control 270 
group. However, they showed a cluster of GM increase relative to the controls 271 
situated in the basal ganglia, specifically in the left caudate nucleus and putamen 272 
(cluster size: 15 voxels; uncorrected p=0.001; MNI x=-8 y=12 z=-2) (see Table 2 and 273 
Figure 1). This finding did not survive the correction for multiple comparisons. 274 
 275 
3.4. Correlational analysis  276 
 277 
There was a significant positive correlation between the cumulative stimulant dose 278 
and the clusters of GM reduction in the right SMA (extending to the superior frontal 279 
cortex) and in the right DLPFC (see Table 2 and Figure 2). Specifically, higher 280 
cumulative dose was associated with larger (i.e. less abnormal) volume of these 281 
areas. There were no statistical significant correlations with clinical measures. 282 
 283 
 284 
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4. Discussion 285 
 286 
The aim of this study was to evaluate whether there are volumetric differences 287 
between adults with ADHD and healthy subjects. A modulated VBM analysis showed 288 
a macroscopic reduction of GM volume in the right SMA, the subgenual ACC and the 289 
right DLPFC. Using the unmodulated approach we found a mesoscopic increase of 290 
GM density in the left caudate and putamen nuclei. Only the abnormality in SMA 291 
survived the correction for multiple comparisons, and no statistically significant 292 
alterations were detected in brain regions reported in other studies such as the 293 
orbitofrontal cortex, the occipital and parietal lobes and the cerebellum (Ahrendts et 294 
al., 2011; Hesslinger et al., 2002; Pironti et al., 2014; Seidman et al., 2011; Seidman 295 
et al., 2006).  296 
 297 
This is the first volumetric study in ADHD adult population that has shown smaller GM 298 
in the SMA. Functional neuroimaging studies suggest that a network of fronto-parietal 299 
brain regions -including the inferior prefrontal, medial prefrontal (the SMA and pre-300 
SMA) and inferior parietal areas, are implicated in motor response inhibition (Hart et 301 
al., 2013), with SMA as one of the key motor inhibition areas (Hart et al., 2014). This 302 
may be significant, since some psychological theories have proposed that ADHD 303 
symptoms result from a primary deficit in inhibitory control (Barkley, 1997). In this 304 
respect it is also interesting to note that a study carried out in pediatric ADHD patients 305 
found that the left supplementary motor complex (SMC) emerged as the most 306 
anomalous frontal lobe region in these patients (Mahone et al., 2011).  307 
 308 
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Despite reductions in ACC and DLPFC were only significant using lenient thresholds, 309 
they support the findings of Amico et al. (2011) and Seidman et al. (2006, 2011)  310 
showing a smaller volume in ACC and the DLPFC in adult patients with ADHD.  311 
According to previous literature in childhood, our findings are also consistent with  312 
respect to significant reductions in these structures (De La Fuente et al., 2013). On  313 
the one hand, the role of the ACC is far beyond the processing and regulation of  314 
emotional information, i.e. the projections from the ACC to the motor cortex and  315 
spinal cord seem to implicate this region in motor control (Frodl and Skokauskas, 316 
2012). In fact, a meta-analysis published by Hart et al. (2013) in functional MRI,  317 
reports that both the SMA and the ACC showed a decreased activation in patients  318 
with ADHD compared with healthy controls during performance of different inhibition  319 
tasks (Hart et al., 2013). Relative to the DLPFC it is an important region involved in  320 
the executive functions which are highly affected in ADHD patients. In fact,  321 
anatomical studies in children have shown volume reductions in this structure relative  322 
to controls and functional studies have shown underactivation of the DLPFC during  323 
different cognitive and motor tasks. Therefore, many investigators hypothesize  324 
DLPFC dysfunction in the etiology of the disorder (Cubillo et al., 2012; Seidman et 325 
al., 2006). 326 
 327 
Our data do not replicate the results of Seidman et al. (2011) and Almeida et al. 328 
(2010) of significantly less volume in putamen and caudate nuclei in adult patients 329 
with ADHD. On the contrary, our results showed a cluster of GM increase relative to 330 
the healthy comparison group in the basal ganglia (left caudate and putamen nuclei), 331 
supporting a positive association in ADHD patients between age and GM increase in 332 
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these regions. Caudate and putamen integrate the fronto-striato-thalamo-cortical 333 
circuit, mediating cognitive executive functions and motor activity, typically impaired 334 
in ADHD. Volumetric reductions in basal ganglia typically reported in childhood 335 
ADHD, would not only seem to diminish over time from childhood to adulthood, but 336 
the size of these structures in adult ADHD could actually increase in relation to 337 
healthy controls, as a compensatory striatal overgrowth of frontal deficits to prevent 338 
cognitive and motor behavioral inhibitory output impairment. These data support the 339 
results found in the last meta-analyses by Nakao et al. (2011) and Frodl and 340 
Skokauskas (2012), reporting a positive association between age and GM increase in 341 
the basal ganglia in ADHD patients. However, our findings in basal ganglia were not 342 
significant after correction for multiple comparisons and should thus be taken with 343 
caution. 344 
 345 
The correlation analysis showed no correlation between clinical measures and the 346 
volumetric abnormalities. However, there was a significant correlation between 347 
cumulative stimulant dose and the volume of the right SMA and the right DLPFC; this 348 
was positive in both cases, i.e. a greater exposure to stimulant treatment was 349 
associated with less volume reduction. Previous studies using the ROI approach 350 
found that pediatric patients who had been medicated with psychostimulants did not 351 
show volume reductions in regions like the ACC, the pulvinar nucleus of the 352 
thalamus, the posterior inferior cerebellum and the corpus callosum compared with 353 
typically developing children (Bledsoe et al., 2009; Ivanov et al., 2014; Semrud-354 
Clikeman et al., 2006), suggesting a neuroprotective effect of stimulants on brain 355 
development in the disorder (Rubia et al., 2013). A further study using cortical 356 
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thickness analysis also found evidence that unmedicated children with ADHD showed 357 
excessive cortical thinning compared with control subjects, whereas children treated 358 
with  psychostimulants did not (Shaw et al., 2009). Finally, a recent meta-analysis of 359 
VBM studies found that long-term stimulant medication was associated with more 360 
normal basal ganglia structure (Nakao et al., 2011). The effects of  stimulant 361 
treatment on brain function in ADHD patients has received more attention, with 362 
reports that methylphenidate induces acute normalization of activation patterns in 363 
different networks of the brain such as the fronto-striatal and the fronto-cingulate that 364 
include brain regions that have been associated with structural and functional 365 
changes in ADHD (Rubia et al., 2011a; Rubia et al., 2011b). 366 
 367 
This study has some limitations. First, results other than those in SMA did not survive 368 
after correction for multiple comparisons and should be thus taken with caution. 369 
Second, neuropsychological assessment was not sufficient in order to conduct an 370 
analysis of correlation between the brain changes found and  neuropsychological 371 
measures, therefore we could not assess whether there was an association between 372 
these variables. Finally, it is important to remember that the cases with comorbid 373 
substance abuse and other major psychiatric disorders in Axis I and II were excluded 374 
from the study, so there is a limitation to generalize the result of the study to ADHD 375 
subjects with other substance use or psychiatric disorders. However, the use of a 376 
clinical sample with no comorbidities, whilst a possible limitation for generalizing our 377 
results provided that comorbidity is very prevalent in adult ADHD (Asherson et al., 378 
2007; Kessler et al., 2006), is the only way to enable a better characterization of 379 
ADHD per se in order to attribute neuroimaging findings to the disorder itself.  380 
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 381 
In summary, our results in a large sample of ADHD adults using a whole brain VBM 382 
analysis show that patients with ADHD have a GM volume reduction in the right SMA, 383 
the subgenual ACC and the right DLPFC and an increase of GM density in the left 384 
caudate and putamen relative to controls. All these regions mediate cognitive and 385 
motoric functions such as motor response and interference inhibition, cognitive 386 
flexibility, temporal foresight, selective and sustained attention, working memory, 387 
motor and timing processes which are dysfunctional in ADHD patients (Castellanos et 388 
al., 2006; Cubillo et al., 2012). Findings of GM reduction circumscribed to frontal 389 
regions only, with no significant findings for cerebellar, occipital, temporal nor parietal 390 
regions in our adult ADHD sample, give support to the hypothesis of developmental 391 
structural brain differences in ADHD normalizing with increasing age (Onnink et al., 392 
2014; Shaw et al., 2007), with maintenance of volume reduction only with respect to 393 
frontal lobe during adulthood.  394 
 395 
 396 
 397 
 398 
 399 
 400 
 401 
 402 
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LEGENDS 648 
Table 1 649 
TAP, Word Accentuation Test (Test de Acentuación de Palabras); TAP_FISQ, TAP-650 
estimated Full-scale IQ; IQ, intelligence quotient; WAIS, Wechsler Adult Intelligence 651 
Scale; WURS, Wender Utah Rating Scale; ADHD, Attention Deficit Hyperactivity 652 
Disorder; CAARS, Conners Adult ADHD Rating Scale; DSM, Diagnostic and 653 
Statistical Manual of Mental Diseases. 654 
 655 
Table 2 656 
Analyses covaried by age, sex and cumulated stimulant dose. (a) p < 0.001 657 
uncorrected for multiple comparisons, 10 voxels extent threshold. (b) This result was 658 
also significant (p < 0.05) after correction for multiple comparisons. ADHD Attention 659 
Deficit Hyperactivity Disorder, SMA supplementary motor area, ACC anterior 660 
cingulated cortex, DLPFC dorsolateral prefrontal cortex. r, Pearson correlation 661 
coefficient; n.s, no significant. 662 
 663 
Figure 1  664 
Volumetric differences in patients with ADHD relative to healthy subjects. Areas in 665 
blue indicate a significant less gray matter in patients relative to control group; areas 666 
in red indicate a significant more gray matter density in ADHD compared to controls. 667 
Reductions in ACC and DLPFC and increase in basal ganglia were not significant 668 
after correction for multiple comparisons. 669 
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 670 
Figure 2  671 
Boxplots and scatterplots of the relationships between gray matter, group (healthy 672 
controls, drug-naïve patients and medicated patients) and cumulated medication 673 
dose. 674 
Table 1. Demographic and clinical characteristics of the sample 675 
  
ADHD N=44 
Mean (SD) 
 
Control N=44 
Mean (SD) 
 
P value 
 
χ
2 
value 
Age (years) 31.61 (11.38) 
29/15 
17.96 (3.76) 
22.42 (4.49) 
101.24 (8.06) 
105.00 (7.53) 
51.95 (11.09) 
32.15 (9.12) 
 
22.29 (7.68) 
20.80 (8.45) 
18.56 (7.84) 
9.51 (4.34) 
17.49 (4.88) 
15.80 (6.64) 
33.29 (9.85) 
21.61 (6.08) 
32.57 (10.63) 0.68  
Sex (male/female) 
Education (years) 
29/15 
18.38 (4.53) 
 
0.70 
1.00 
TAP, mean 23.10 (3.88) 0.47  
TAP_FISQ 102.38 (7.45) 0.53  
Current IQ (WAIS-III)  105.97 (11.38) 0.66  
WURS     
ADHD Rating Scale    
CAARS 
 Inattention 
 Hyperactivity 
 Impulsivity 
 Problems with self-concept 
 DSM-IV inattentive symptoms 
 DSM-IV hyperactivity-impulsivity symptoms 
 DSM-IV total ADHD symptoms 
 ADHD Index 
   
 676 
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 677 
 678 
 679 
Table 2. Gray matter volumetric differences between patients with ADHD and healthy controls. 680 
 
Peak  
 
Cluster 
size 
 
Association with 
cumulative 
stimulant dose 
MNI P (a) 
 
Macroscopic changes (modulated 
data) 
 
      
Increases of volume (ADHD > 
Controls) 
      
       
(none)       
       
Decreases of volume (ADHD < 
Controls) 
      
       
Right SMA, extending to 
superior frontal 
8,24,64 <0.001 
(b) 
 889  r = 0.451 (p = 
0.002) 
       
Subgenual ACC 6,18,-14 <0.001  53  n.s. 
       
Right dorsolateral prefrontal 
cortex 
48,18,44 <0.001  16  r = 0.407 (p = 
0.006) 
       
Mesoscopic changes (unmodulated 
data) 
      
 
Increases of volume (ADHD > 
Controls) 
      
       
Left caudate and putamen -8,12,-2 0.001  15  n.s. 
       
Decreases of volume (ADHD < 
Controls) 
      
       
(none)       
       
 681 
(a) p < 0.001 uncorrected for multiple comparisons, 10 voxels extent threshold. 682 
(b) This result was also significant (p < 0.05) after FWE-correction for multiple comparisons. 683 
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Highlights 688 
 689 
 Anatomical MRI images are obtained using voxel-based morphometry (VBM) 690 
from a large sample of adults with ADHD-Combined subtype and a matched 691 
group of healthy volunteers 692 
 693 
 ADHD adults show structural abnormalities in key regions of cognitive control 694 
 695 
 Long-term stimulant medication may act to normalize brain structural deficits in 696 
patients with ADHD 697 
 698 
 699 
 700 
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